Europe’s health policies ‘must change’ with stakeholders leaving their ‘comfort zones’
24 Oct 2014
“Patients are waiting for therapeutic improvement and asking us – while we have good technologies – are we really bringing them the best new drugs? And if we look hard in the mirror the fact is that we are not using technology optimally”, said Dr. Denis Lacombe, EORTC Director. “There needs to be more collaboration, new models…and that means we have to think outside the box.”
Read the entire interview here
Related News
World Cancer Day: How clinical cancer research changes lives
4 Feb 2026
New international study shows access to patient-reported outcome data improves the consistency of the evaluation of cancer treatment adverse events
27 Jan 2026
First Site Activated and First Patient Randomised in new brain cancer study VIGOR – EORTC‑2427‑BTG
26 Jan 2026
EORTC and EMA, jointly with international stakeholders, have published a multistakeholder roadmap to accelerate treatment optimisation in oncology
16 Jan 2026
New EORTC quality of life questionnaire for adolescents and young adults with cancer
8 Jan 2026
P-Value Workshop
19 Dec 2025
EORTC participation at ISPOR Europe 2025 conference
7 Nov 2025
EORTC Quality of Life Group participating at the ISOQOL 2025 Conference
22 Oct 2025
New results and forthcoming trials presented at ESMO 2025 underline EORTC’s commitment to patient-centred research
21 Oct 2025
EORTC celebrates the 100th anniversary of p-value on World Statistics Day
20 Oct 2025
